ProfileGDS4718 / 206822_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 18% 15% 23% 13% 15% 28% 37% 13% 17% 12% 21% 10% 20% 32% 15% 18% 17% 13% 27% 23% 11% 18% 16% 14% 13% 15% 11% 40% 14% 19% 23% 30% 16% 21% 36% 27% 19% 12% 17% 30% 18% 29% 31% 49% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.083818
GSM549102patient 115, normal, homogenized [OPG study]3.9596315
GSM549104patient 119, normal, homogenized [OPG study]4.2303723
GSM549108patient 138, normal, homogenized [OPG study]3.9128413
GSM549119patient 077, normal, homogenized [OPG study]3.9809615
GSM549133patient 032, cancer, homogenized [OPG study]4.4108428
GSM549139patient 042, cancer, homogenized [OPG study]4.8412537
GSM549099patient 107, normal, homogenized [OPG study]3.8890413
GSM549109patient 139, normal, homogenized [OPG study]4.0730717
GSM549110patient 046, normal, homogenized [OPG study]3.8586512
GSM549114patient 063, normal, homogenized [OPG study]4.1311821
GSM549122patient 082, normal, homogenized [OPG study]3.787210
GSM549134patient 033, cancer, homogenized [OPG study]4.1510520
GSM549136patient 036, cancer, homogenized [OPG study]4.5866632
GSM549140patient 044, cancer, homogenized [OPG study]3.9460815
GSM549111patient 047, normal, homogenized [OPG study]4.0295118
GSM549113patient 057, normal, homogenized [OPG study]3.9759517
GSM549132patient 031, cancer, homogenized [OPG study]3.8859213
GSM549137patient 038, cancer, homogenized [OPG study]4.4164127
GSM549142patient 047, cancer, homogenized [OPG study]4.3518123
GSM549100patient 110, normal, homogenized [OPG study]3.827911
GSM549107patient 135, normal, homogenized [OPG study]4.0541318
GSM549115patient 068, normal, homogenized [OPG study]3.9535716
GSM549116patient 072, normal, homogenized [OPG study]3.9101314
GSM549120patient 078, normal, homogenized [OPG study]3.8908413
GSM549131patient 030, cancer, homogenized [OPG study]3.9174915
GSM549118patient 074, normal, homogenized [OPG study]3.8221511
GSM549129patient 027, cancer, homogenized [OPG study]4.9944740
GSM549123patient 088, normal, homogenized [OPG study]3.918814
GSM549124patient 006, cancer, homogenized [OPG study]4.160119
GSM549126patient 015, cancer, homogenized [OPG study]4.2476723
GSM549128patient 025, cancer, homogenized [OPG study]4.5315630
GSM549103patient 117, normal, homogenized [OPG study]4.034316
GSM549117patient 073, normal, homogenized [OPG study]4.172321
GSM549138patient 041, cancer, homogenized [OPG study]4.8000436
GSM549141patient 045, cancer, homogenized [OPG study]4.3544827
GSM549130patient 028, cancer, homogenized [OPG study]4.1377619
GSM549101patient 111, normal, homogenized [OPG study]3.8462312
GSM549105patient 128, normal, homogenized [OPG study]4.0548517
GSM549106patient 134, normal, homogenized [OPG study]4.4997730
GSM549112patient 048, normal, homogenized [OPG study]4.0806818
GSM549125patient 011, cancer, homogenized [OPG study]4.4913729
GSM549127patient 024, cancer, homogenized [OPG study]4.5484231
GSM549135patient 035, cancer, homogenized [OPG study]5.4520949